A More Persuasive Justification for Pediatric Research

American Journal of Bioethics

Volumn 12, Issue 1, 2012, Pages 44-46

  Litton, Paul ^a  

^a UNIVERSITY OF MISSOURI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTRUISM; ARTICLE; CLINICAL TRIAL (TOPIC); CONFLICT OF INTEREST; ETHICS; HUMAN; HUMAN EXPERIMENT; INFORMED CONSENT; PARENT; PEDIATRICS; PERSONAL AUTONOMY;

ALTRUISM; CLINICAL TRIALS AS TOPIC; CONFLICT OF INTEREST; HUMANS; INFORMED CONSENT BY MINORS; NONTHERAPEUTIC HUMAN EXPERIMENTATION; PARENTS; PEDIATRICS; PERSONAL AUTONOMY;

EID: 84855963993     PISSN: 15265161     EISSN: 15360075     Source Type: Journal    
DOI: 10.1080/15265161.2011.638038     Document Type: Article

References (3)

1. Food and Drug Administration. 1998, December 2. Regulations Requiring Manufacturers To Assess the Safety and Effectiveness of New Drugs and Biologic Products in Pediatric Patients, 63 Fed. Reg. 66,632.
2. Litton, P. 2008. Non-beneficial pediatric research and the best interests standard: A legal and ethical reconciliation. Yale Journal of Health Policy, Law & Ethics, 8(2): 359-420.
3. Wendler, D. 2012. A new justification for pediatric research without the potential for clinical benefit. American Journal of Bioethics, 12(1): 23-31.